Login
+44 203 371 1100
Login
+44 203 371 1100
Credit Sector:- Health Care
Country:- United States
Bond Document:- https://www.bondpdf.com
In order to view the complete data, please login here
| Announcement Date | CA Type | CA Impact | CA Event | ISIN |
|---|---|---|---|---|
| 10-Oct-2018 | Acquisition | Acquired Name | Vernalis PLC | US00214WAE12 |
| Ligand Pharmaceuticals Incorporated today announced that it has acquired Vernalis PLC. | ||||
| 09-Aug-2018 | Propose Acquisition | Target Name | Vernalis PLC | US00214WAE12 |
| Ligand Pharmaceuticals Incorporated announced today that it intends to acquire Vernalis PLC. | ||||
| 22-May-2018 | New Bond | - | - | US53220KAE82 |
| Ligand Pharmaceuticals Incorporated has issued USD 650MM, 0.750% fixed rate bond due 15-May-2023. | ||||
| 15-May-2019 | New Bond | - | - | US53220KAF57 |
| Ligand Pharmaceuticals Incorporated has issued USD 750MM, Fixed rate Bond due 15-May-2023. | ||||
| 23-Jul-2019 | Propose Acquisition | Target Name | AB Initio Biotherapeutics, Inc. | US00214WAE12 |
| Ligand Pharmaceuticals Incorporated announced today that it intends to acquire AB Initio Biotherapeutics, Inc. | ||||
All of the financial data available on this page is sourced from FactEntry.